Intron 10 was targeted with two sgRNAs using CRISPR/Cas9 technology, resulting in a 169 bp deletion (GRCm39:chr17:27178159-27178327). This deletion does not eliminate the alternative 3' splice acceptor site that is used for NMD-mediated transcriptional regulation. (J:334714)